Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Scemblix by Quarter
Scemblix — First-Line New Prescription (1L CML NBRx) Market Share in the US (%)
Novartis Scemblix: 33.0% in Q3 2026, up 11.0 pts from a year earlier.
Latest, Q3 2026
33.0%
Period ended Sep 30, 2026
Change on a year earlier
+11.0 pts
22.0% in Q3 2025
History
7 quarters
Since Q1 2025
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
“| • Achieved 1L NBRx leadership with 33%”
Source: Novartis Official IR / Sustainability Report — q3-2026-investor-presentation.pdf ↗
Reported in Quarterly Investor Presentations.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scemblix — First-Line New Prescription (1L CML NBRx) Market Share in the US (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 33.0% | +11.0 pts | Novartis Official IR / Sustainability Report — q3-2026-investor-presentation.pdf ↗ |
| Q2 2026 | Jun 30, 2026 | 28.0% | +13.0 pts | Novartis Official IR / Sustainability Report — q2-2026-investor-presentation.pdf ↗ |
| Q1 2026 | Mar 31, 2026 | 31.0% | +21.0 pts | Novartis Official IR / Sustainability Report — q1-2026-investor-presentation.pdf ↗ |
| Q4 2025 | Dec 31, 2025 | 23.0% | – | Novartis Official IR / Sustainability Report — q4-2025-investor-presentation.pdf ↗ |
| Q3 2025 | Sep 30, 2025 | 22.0% | – | Novartis Official IR / Sustainability Report — q3-2025-investor-presentation.pdf ↗ |
| Q2 2025 | Jun 30, 2025 | 15.0% | – | Novartis Official IR / Sustainability Report — q2-2025-investor-presentation.pdf ↗ |
| Q1 2025 | Mar 31, 2025 | 10.0% | – | Novartis Official IR / Sustainability Report — q1-2025-investor-presentation.pdf ↗ |
Breakdown
What makes up scemblix
Cite this data
StockData. (2026). Novartis Scemblix (%), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rx-scemblix-us-1l-nbrx-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.